本页汇总 人参皂甙 的 9 篇安全性公开文献，按毒性终点分区，逐条标注研究类型、物种、染毒途径与来源。以上均为各原研究/评估机构的结论，本平台不作再评价，也不构成对该成分的安全性判定。
含PPD和不含PPD的NLC制剂在人体研究中均无皮肤刺激性。
NLC formulations with and without PPD were not skin irritants in a human study.
ELHPP-RGBPs在皮肤刺激试验中显示毒性很低。
ELHPP-RGBPs were found to be very low in toxicity in skin irritation tests.
10%红参和10%发酵红参在皮肤刺激试验中均被归类为实际无刺激性；但红参组致敏率100%，发酵红参组致敏率20%，表明红参有致敏风险，发酵后风险降低。
10% RG and 10% FRG were classified as practically nonirritating in skin irritation test; however, RG showed 100% sensitization rate while FRG showed 20%, indicating RG has sensitization risk which is reduced by fermentation.
红参组致敏率100%，评分1.4，证实红参有致敏风险；发酵红参致敏率降低至20%，但红参本身有风险。
RG group showed 100% sensitization rate and mean irritation score 1.4, confirming sensitization risk; FRG reduced to 20%, but RG itself poses risk.
口服G1899高达5000 mg/kg/day未观察到系统、发育、生殖毒性或雌激素活性；NOAEL≥5000 mg/kg/day，提示高剂量下安全。
Oral G1899 up to 5000 mg/kg/day showed no systemic, developmental, reproductive toxicity or estrogenic activity; NOAEL ≥5000 mg/kg/day, indicating safety at high doses.
综述讨论人参对化学毒物的保护机制，未直接评估人参皂苷的生殖毒性或孕期风险。
Review discusses protective mechanisms of ginseng against chemical toxicants, does not directly assess reproductive toxicity or pregnancy risk of ginsenosides.
该文献研究人参皂苷对BPA毒性的保护作用，而非人参皂苷本身的生殖毒性；不涉及孕期风险。
This study investigates the protective effect of ginsenosides against BPA toxicity, not the reproductive toxicity of ginsenosides themselves; not relevant to pregnancy risk.
队列研究显示孕期使用人参无不良影响，但体外动物胚胎研究显示高浓度人参皂苷有致畸性；证据矛盾，且体外暴露水平远高于人体正常摄入。
Cohort study showed no adverse effects of ginseng use during pregnancy, but in vitro animal embryo studies showed teratogenicity at high concentrations of ginsenosides; conflicting evidence, and in vitro exposure levels far exceed normal human intake.
50 μg/ml Re导致胚胎发育参数显著降低，但5 μg/ml Re无影响，且Rc无影响；提示剂量依赖性胚胎毒性，但为体外高浓度暴露，与化妆品外用剂量相关性有限。
50 μg/ml Re significantly reduced embryonic development parameters, but 5 μg/ml Re had no effect, and Rc showed no effect; indicates dose-dependent embryotoxicity, but in vitro high-concentration exposure, limited relevance to cosmetic topical use.
毒理学实验记录来自标准化的毒性试验（如 OECD 导则试验），给出的是剂量/浓度层面的实验值；公开文献是研究者围绕化妆品实际使用场景发表的研究（本页 9 篇），结论均为原作者观点。两类证据并列呈现，本平台不做合并判定。
目前暂无收录含人参皂甙的市售原料。如果贵司供应该原料，欢迎入驻 INCILABS 原料库——您的产品将出现在本页及相关成分页，直接触达正在检索该成分的配方研发人员。